O Shaughnessy Asset Management LLC grew its stake in shares of HCA Healthcare Inc (NYSE:HCA) by 692.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 62,971 shares of the company’s stock after buying an additional 55,027 shares during the period. O Shaughnessy Asset Management LLC’s holdings in HCA Healthcare were worth $8,753,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Smithfield Trust Co. increased its position in shares of HCA Healthcare by 41.2% in the third quarter. Smithfield Trust Co. now owns 1,405 shares of the company’s stock worth $196,000 after purchasing an additional 410 shares during the last quarter. Skandinaviska Enskilda Banken AB publ increased its position in shares of HCA Healthcare by 75.7% in the third quarter. Skandinaviska Enskilda Banken AB publ now owns 83,585 shares of the company’s stock worth $11,628,000 after purchasing an additional 36,000 shares during the last quarter. Janney Montgomery Scott LLC increased its position in shares of HCA Healthcare by 105.5% in the third quarter. Janney Montgomery Scott LLC now owns 9,303 shares of the company’s stock worth $1,294,000 after purchasing an additional 4,777 shares during the last quarter. C WorldWide Group Holding A S increased its position in shares of HCA Healthcare by 16.6% in the third quarter. C WorldWide Group Holding A S now owns 92,727 shares of the company’s stock worth $12,900,000 after purchasing an additional 13,192 shares during the last quarter. Finally, Pendal Group Ltd bought a new position in shares of HCA Healthcare in the third quarter worth approximately $4,719,000. Hedge funds and other institutional investors own 70.84% of the company’s stock.
Several analysts have issued reports on the company. Mizuho reaffirmed a “buy” rating and issued a $145.00 target price on shares of HCA Healthcare in a research note on Thursday, August 2nd. Barclays assumed coverage on HCA Healthcare in a research note on Tuesday, August 14th. They issued an “overweight” rating and a $150.00 target price for the company. ValuEngine raised HCA Healthcare from a “hold” rating to a “buy” rating in a research note on Wednesday, July 18th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $135.00 target price on shares of HCA Healthcare in a research note on Thursday, July 26th. Finally, Credit Suisse Group upped their target price on HCA Healthcare from $122.00 to $143.00 and gave the stock an “outperform” rating in a research note on Friday, July 27th. Two research analysts have rated the stock with a sell rating, four have given a hold rating and sixteen have given a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $141.53.
In other news, SVP Jane D. Englebright sold 6,543 shares of the stock in a transaction that occurred on Wednesday, August 15th. The stock was sold at an average price of $129.86, for a total transaction of $849,673.98. Following the completion of the sale, the senior vice president now owns 7,443 shares of the company’s stock, valued at $966,547.98. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider Michael S. Cuffe sold 5,196 shares of the stock in a transaction that occurred on Friday, November 2nd. The shares were sold at an average price of $136.52, for a total value of $709,357.92. The disclosure for this sale can be found here. In the last three months, insiders have sold 22,486 shares of company stock valued at $3,079,086. Insiders own 2.80% of the company’s stock.
NYSE:HCA opened at $143.95 on Friday. The company has a market cap of $48.75 billion, a PE ratio of 15.92, a P/E/G ratio of 1.24 and a beta of 0.48. HCA Healthcare Inc has a fifty-two week low of $74.26 and a fifty-two week high of $144.18.
HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, October 30th. The company reported $2.16 earnings per share for the quarter, beating analysts’ consensus estimates of $1.93 by $0.23. The firm had revenue of $11.45 billion during the quarter, compared to analyst estimates of $11.29 billion. HCA Healthcare had a negative return on equity of 73.71% and a net margin of 6.82%. The business’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.13 earnings per share. As a group, sell-side analysts forecast that HCA Healthcare Inc will post 9.35 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 28th. Stockholders of record on Monday, December 3rd will be paid a dividend of $0.35 per share. This represents a $1.40 dividend on an annualized basis and a dividend yield of 0.97%. The ex-dividend date is Friday, November 30th. HCA Healthcare’s dividend payout ratio (DPR) is presently 21.24%.
WARNING: This piece of content was originally published by American Banking News and is the property of of American Banking News. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The original version of this piece of content can be viewed at https://www.americanbankingnews.com/2018/11/10/o-shaughnessy-asset-management-llc-has-8-75-million-stake-in-hca-healthcare-inc-hca.html.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Featured Story: How to Invest in Growth Stocks
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.